The images above are shown for illustration purposes only. They may not be an exact representation of the product.

N-Acetylcysteine (NAC) + NeilMed Sinus Rinse

N-Acetylcysteine (NAC) + NeilMed Sinus Rinse is a compounded sinus irrigation formulation that may be prescribed when a provider requests NAC in a customized nasal rinse protocol.

N-acetylcysteine (NAC) is a powerful adjunct in ENT care, especially for chronic sinusitis, post-surgical recovery, and infections involving resistant bacteria or fungi. While traditionally used as a mucolytic to thin mucus, compounded NAC offers added benefits as a biofilm disruptor and quorum sensing inhibitor—breaking down the protective matrix that shields bacteria and allowing antibiotics to work more effectively. ENT specialists often use NAC in customized sinus rinses, nebulized solutions, or ear drops to address complex conditions like MRSA sinusitis, fungal infections, nasal polyps, and cystic fibrosis–related airway issues. When paired with agents like mupirocin, amphotericin B, tobramycin, or budesonide, NAC helps target biofilms, reduce inflammation, and improve patient outcomes. Compounded formulations from accredited pharmacies like HDRx allow for tailored treatment strategies and optimized delivery across ENT care. Read more about NAC here →

NeilMed Sinus Rinse is a trusted, easy-to-use nasal irrigation system designed to flush out mucus, allergens, and debris from the nasal passages. Often recommended by ENT providers, it’s also used to deliver compounded medications like antibiotics, corticosteroids, antifungals, and NAC for chronic rhinosinusitis or post-surgical care.

This medication requires a prescription.

Additional Information

N-Acetylcysteine (NAC) + Mupirocin is a compounded prescription formulation prepared at a provider’s discretion. This combination may be requested when a prescriber determines that a customized sinus rinse containing both a mucolytic component and an antimicrobial ingredient is appropriate for the patient’s care plan.

N-acetylcysteine is commonly referenced in clinical literature for its ability to influence mucus viscosity and biofilm structures, which may allow antimicrobial agents such as mupirocin to interact more directly with bacteria that can become embedded within sinus biofilms. Compounding allows these ingredients to be prepared in specific concentrations and delivery formats tailored to a provider’s protocol.

This formulation may be considered in situations where a provider has identified persistent sinus concerns and prefers a compounded preparation rather than commercially available options. As with all compounded medications, strengths, ingredients, and dosage instructions are determined by the prescribing healthcare professional.

To learn more about the role of N-acetylcysteine in biofilm and quorum-sensing research, see compounded acetylcysteine and biofilm research overview.

The formulas and/or statements listed are provided for educational purposes only. They are compounding ideas that have commonly been requested by physicians, and have not been evaluated by the Food and Drug Administration. Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.
Search